预防老年人严重呼吸道疾病效力为80%,杨森RSV疫苗达到2b期临床终点
参考资料:
[1] Janssen Announces Start of Phase 3 Trial for Investigational Respiratory Syncytial Virus (RSV) Vaccine in Older Adults. Retrieved October 3, 2021, from https://www.janssen.com/janssen-announces-start-phase-3-trial-investigational-respiratory-syncytial-virus-rsv-vaccine-older
[2] Janssen Announces Phase 2b Data Demonstrating its Investigational RSV Adult Vaccine Provided 80% Protection Against Lower Respiratory Infections in Older Adults. Retrieved October 3, 2021, from https://www.prnewswire.com/news-releases/janssen-announces-phase-2b-data-demonstrating-its-investigational-rsv-adult-vaccine-provided-80-protection-against-lower-respiratory-infections-in-older-adults-301391246.html
来源:药明康德
不感兴趣
看过了
取消
人点赞
人收藏
打赏
不感兴趣
看过了
取消
您已认证成功,可享专属会员优惠,买1年送3个月!
开通会员,资料、课程、直播、报告等海量内容免费看!
打赏金额
认可我就打赏我~
1元 5元 10元 20元 50元 其它打赏作者
认可我就打赏我~
扫描二维码
立即打赏给Ta吧!
温馨提示:仅支持微信支付!
已收到您的咨询诉求 我们会尽快联系您